Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MARIMED INC.MRMD · Entity 7423 | Director | June 06, 2025 | June 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MARIMED INC.
Report date June 06, 2025 · Filed June 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 350,000 |
Reported balance
After 2025-06-06 transaction · row 1
1 source rowRow 1 · 2025-06-06 · Exercise / conversion · Acquired 75,000 · Balance 350,000 F1: RSUs convert to shares of common stock on a one-for-one basis. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-06 · Exercise / conversion · Disposed 0 · Balance 0 F1: RSUs convert to shares of common stock on a one-for-one basis. F2: The RSUs were granted on June 6, 2024 and vested in full on June 6, 2025 in accordance with the terms of an agreement between the Issuer and the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: RSUs convert to shares of common stock on a one-for-one basis.
F2: The RSUs were granted on June 6, 2024 and vested in full on June 6, 2025 in accordance with the terms of an agreement between the Issuer and the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2025 Filed Jun 6, 2025 19:23 UTC | MARIMED INC. MRMD · Entity 7423 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001522767-25-000107 · wk-form4_1749252230.xml · derivative · entry 2 Tucker Kathleen · CIK 0001972688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.001 per share · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSUs convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs were granted on June 6, 2024 and vested in full on June 6, 2025 in accordance with the terms of an agreement between the Issuer and the Reporting Person. F2 · derivative.expiration_date: The RSUs were granted on June 6, 2024 and vested in full on June 6, 2025 in accordance with the terms of an agreement between the Issuer and the Reporting Person. Read SEC document |
| June 06, 2025 Filed Jun 6, 2025 19:23 UTC | MARIMED INC. MRMD · Entity 7423 | Exercise / conversionCommon stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001522767-25-000107 · wk-form4_1749252230.xml · nonDerivative · entry 1 Tucker Kathleen · CIK 0001972688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: RSUs convert to shares of common stock on a one-for-one basis. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 17:07 UTC | MARIMED INC. MRMD · Entity 7423 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001522767-24-000057 · wk-form4_1718053665.xml · derivative · entry 3 Tucker Kathleen · CIK 0001972688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $.001 per share · 75,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: RSUs convert to shares of common stock on a one-for-one basis. F3 · derivative.exercise_date: The RSUs vested fully on the one-year anniversary of the June 8, 2023 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. F3 · derivative.expiration_date: The RSUs vested fully on the one-year anniversary of the June 8, 2023 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. Read SEC document |
| June 08, 2024 Filed Jun 10, 2024 17:07 UTC | MARIMED INC. MRMD · Entity 7423 | Exercise / conversionCommon stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001522767-24-000057 · wk-form4_1718053665.xml · nonDerivative · entry 1 Tucker Kathleen · CIK 0001972688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: RSUs convert to shares of common stock on a one-for-one basis. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 17:07 UTC | MARIMED INC. MRMD · Entity 7423 | GrantRestricted Stock Units (RSU) · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001522767-24-000057 · wk-form4_1718053665.xml · derivative · entry 2 Tucker Kathleen · CIK 0001972688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock, par value $.001 per share · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: RSUs convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs vest fully on the one-year anniversary of the June 6. 2024 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. F2 · derivative.expiration_date: The RSUs vest fully on the one-year anniversary of the June 6. 2024 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. Read SEC document |
| June 08, 2023 Filed Jun 8, 2023 17:08 UTC | MARIMED INC. MRMD · Entity 7423 | GrantRestricted Stock Units (RSU) · Derivative | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001522767-23-000090 · wf-form4_168625847732933.xml · derivative · entry 2 Tucker Kathleen · CIK 0001972688 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock, par value $.001 per share · 75,000 shares Expires not disclosed F1 · derivative.exercise_price: RSUs convert to shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: The RSUs vest fully on the one-year anniversary of the June 8, 2023 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. F2 · derivative.expiration_date: The RSUs vest fully on the one-year anniversary of the June 8, 2023 grant date, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.